Rus
Eng
Yury Gogotsi, Drexel University, Philadelphia, PA, Rodney S. Ruoff, IBS CMCM Center and Ulsan National Institute of Science and Technology, South Korea, and Patrice Simon, Université Paul Sabatier Toulouse III – CNRS, Toulouse, France, are celebrated in Physics for discoveries advancing the understanding and development of carbon-based materials including for capacitive energy storage and understanding the mechanisms of operation of supercapacitors.
This designation celebrates researchers whose influence is comparable to that of Nobel Prize recipients, as attested by exceptionally high citation records within the Web of Science. Clarivate Analytics, the global leader in providing trusted insights and analytics to enable researchers to accelerate discovery selects the world-class researchers whose research has been cited at high frequency – with papers typically in the top 0.01% globally most-cited – and whose contribution to science has been transformative, even revolutionary, as they join the hall of Citation Laureates and take their place among the world-class of global researchers.
On October 1st, 2018, the Nobel Assembly will vote to confer sciences’ highest honor and whilst this annual rite inspires worldwide speculation, Clarivate Analytics is the only organization to use quantitative data to make annual forecasts of potential Nobel Prize recipients. To date, 46 Citation Laureates have gone on to receive a Nobel Prize, 27 within two years of being listed.
Authors of extremely highly cited papers (to be cited 2,000 times or more is a rarity indeed) are usually members of their national academies of sciences, hold high appointments in universities and other research institutes, or have received many top international prizes in their fields. They often go on to receive Nobel honors. While peer review remains the principal method to recognize research excellence, a parallel approach of appraising the citation record often provides important corroborating evidence to supplement peer review.
Source: https://clarivate.com
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
